Revance Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Revance Therapeutics shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $16M | 20M | 0.81 |
| 2022-12-31 | $27M | 29M | 0.93 |
| 2022-09-30 | $22M | 20M | 1.08 |
| 2022-06-30 | $16M | 20M | 0.82 |
| 2022-03-31 | $19M | 20M | 0.96 |